Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositisMichael O. Harris‐Love, Lisa G. Rider, B. Moini et al.|Lara D. Veeken|2008Cited by 132
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Mark F. Gourley, Angelina Pokrovnichka et al.|Seminars in Arthritis and Rheumatism|2017Cited by 70